Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.

Oncogene - 20 Mar 2014

Reyes D, Ballaré C, Castellano G, Soronellas D, Bagó J R, Blanco J, Beato M

Abstract excerpt

Growth of breast cancers is often dependent on ovarian steroid hormones making the tumors responsive to antagonists of hormone receptors. However, eventually the tumors become hormone independent, raising the need to identify downstream targets for the inhibition of tumor growth. One possibility...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin
Share to Estradiol
Share to Estrogens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to G1 Phase

Share to Progestins

Share to Receptors, Progesterone

Share to Ribosomal Protein S6 Kinases, 90-kDa

Share to S Phase

Source

Identifiers

PMID: 23604116
DOI: 10.1038/onc.2013.95

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23604116-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.PMID 23604116Read ↗

BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer.Semantic proximity Read ↗

FGF2 induces breast cancer growth through ligand‐independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequencesSemantic proximity Read ↗

Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.Semantic proximity Read ↗

Progesterone Receptor–Cyclin D1 Complexes Induce Cell Cycle–Dependent Transcriptional Programs in Breast Cancer CellsSemantic proximity Read ↗

Depletion of BRCA1 Potentiates Progestin-Induced Cytoskeletal Changes in an Ovarian Cancer Cell ModelSemantic proximity Read ↗

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling.Semantic proximity Read ↗

Hormone-Induced Chromosomal Instability in p53-Null Mammary EpitheliumSemantic proximity Read ↗

miR-489 Confines Uncontrolled Estrogen Signaling Through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast CancerSemantic proximity Read ↗

Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells.Semantic proximity Read ↗

Estrogen-Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell ProliferationSemantic proximity Read ↗

Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progressionSemantic proximity Read ↗

Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.